BreastView
AI‑powered mammography assistant for earlier detection
BreastView detects suspicious lesions on mammograms, helping radiologists make faster, more confident decisions, seamlessly integrated into their daily workflow.
BreastView is an AI solution that analyzes mammograms to assist radiologists by highlighting suspicious breast lesions within their routine workflow. It detects soft‑tissue findings such as masses, distortions, and asymmetries, as well as breast microcalcifications, and provides both a malignancy score and breast density assessment.
Discover BreastView at work
Indication
63 y.o. patient presenting as part of organized screening.
Results
BreastView detected a lesion that was a non-specific infiltrating carcinoma
Indication
56 y.o patient presenting as part of organized screening.
Results
BreastView detected a benign cyst and micro-calcifications that were a ductal carcinoma in situ (DCIS).
For Adults
BreastView is intended to be used on adult women aged 18+
Supports on 2D and 2DS
Available on 2D and 2D Synthetic, with 3D Tomosynthesis coming soon.
Specific features
Discover more about BreastView
A suspicion level easy to interpret
For each detection, BreastView’s AI assess the likelihood of malignancy, then maps it into three clear results so radiologists can device faster with confidence.
Assess Breast Density
BreastView estimates breast density for each breast and reports it using the BI‑RADS A–D scale to support interpretation and reporting.
A safety net built to increase radiologist’s confidence
Sensitivity of
85%
for cancer detection¹
Specificity of
93%
for cancerous lesions²
Increase of
29%
in cancer detected with BreastView assistance³
Boost your workflow with the power of advanced integrations
Designed with radiologists, our workflow integrations blend effortlessly into daily routines, enhancing speed, clarity, and confidence at every step.
AI-powered Worklist
Worklist now highlights AI results, findings, and automatically prioritize urgent patients cases.
Shadow Mode
AI results appear on native images, where radiologists can review, accept, or reject, all within their workflow.
Part of Gleamer Copilot
Gleamer Copilot is the all-in-one AI platform that supports radiologists from image to report. It combines powerful detection tools, smart measurements, and structured reporting to boost accuracy and efficiency, all seamlessly integrated into your workflow.
Already implemented in
+2500
Clinical sites
We analyze
+45M
Patients/year
Worldwide presence in
+45
Countries
¹BreastView has a sensitivity of 85% on biopsy-proven malignant lesions
²BreastView has a 93% specificity for cancerous lesions.
³Sensitivity of all radiologists without AI 59.6%, sensitivity of all radiologists with AI 75.5%
For the latest regulatory information, refer to: https://www.gleamer.ai/privacy-policy